Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vaccination against classical swine fever virus: limitations and new strategies

1 Dec 2004

Abstract excerpt

The most widely used vaccines for the control of classical swine fever (CSF) in countries where it is endemic are live attenuated virus strains, which are highly efficacious, inducing virtually complete protection against challenge with pathogenic virus. In the European Union (EU), the combination of prophylactic mass vaccination and culling of infected pigs in endemic regions has made it possible to almost...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Vector-Borne Animal Diseases
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15984328
DOI: 10.1079/ahr200472

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vaccination against classical swine fever virus: limitations and new strategiesPMID 15984328Read ↗

Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: A reviewSemantic proximity Read ↗

A decade of research into classical swine fever marker vaccine CP7_E2alf (Suvaxyn® CSF Marker): a review of vaccine propertiesSemantic proximity Read ↗

Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.Semantic proximity Read ↗

The challenges of classical swine fever control: Modified live and E2 subunit vaccinesSemantic proximity Read ↗

Development of a marker vaccine candidate against classical swine fever based on the live attenuated vaccine C-strain.Semantic proximity Read ↗

Pigs immunized with a novel E2 subunit vaccine are protected from subgenotype heterologous classical swine fever virus challenge.Semantic proximity Read ↗

Classical swine fever vaccines—State-of-the-artSemantic proximity Read ↗

Classical swine fever in China: a minireview.Semantic proximity Read ↗

Porvac® subunit vaccine induces neutralizing antibodies against all three main classical swine fever virus genotypesSemantic proximity Read ↗

Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.Semantic proximity Read ↗

Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization.Semantic proximity Read ↗

Genetically distinct pestiviruses pave the way to improved classical swine fever marker vaccine candidates based on the chimeric pestivirus concept.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.